These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
24. Effect of clopidogrel pretreatment on inflammatory marker expression in patients undergoing percutaneous coronary intervention. Quinn MJ; Bhatt DL; Zidar F; Vivekananthan D; Chew DP; Ellis SG; Plow E; Topol EJ Am J Cardiol; 2004 Mar; 93(6):679-84. PubMed ID: 15019868 [TBL] [Abstract][Full Text] [Related]
25. The effect of different doses of fluvastatin on inflammatory markers in the early phase of acute coronary syndrome. Yang J; Li XP; Zhao SP; Li J; Li JD; Xie XM Clin Chim Acta; 2006 Jun; 368(1-2):183-7. PubMed ID: 16472797 [TBL] [Abstract][Full Text] [Related]
26. Renal angioplasty causes a rapid transient increase in inflammatory biomarkers, but reduced levels of interleukin-6 and endothelin-1 1 month after intervention. Alhadad A; Guron G; Fortuna-Nowakowska E; Saeed A; Mattiasson I; Jensen G; Lindblad B; Gottsäter A; Herlitz H J Hypertens; 2007 Sep; 25(9):1907-14. PubMed ID: 17762656 [TBL] [Abstract][Full Text] [Related]
27. Antianginal response to once-daily diltiazem CD in patients receiving concomitant beta-blockers, long-acting nitrates, or both. Diltiazem CD Study Group. Heller GV; Sridharan M; Morse J; Glasser S; Beach CL Pharmacotherapy; 1997; 17(4):760-6. PubMed ID: 9250554 [TBL] [Abstract][Full Text] [Related]
28. [The influence of beta-adrenoblocking therapy on the markers of systemic inflammation in patients with acute coronary syndrome]. Sisakian AS; Davtian AR; Pepoian SK; Oganesian AS Klin Med (Mosk); 2011; 89(4):56-9. PubMed ID: 21932567 [TBL] [Abstract][Full Text] [Related]
29. Diurnal variation of soluble CD40 ligand in patients with acute coronary syndrome. Soluble CD40 ligand and diurnal variation. Dominguez-Rodriguez A; Abreu-Gonzalez P; Garcia-Gonzalez MJ; Kaski JC Thromb Res; 2009 Feb; 123(4):617-21. PubMed ID: 18579184 [TBL] [Abstract][Full Text] [Related]
31. Myeloperoxidase and C-reactive protein in patients with cocaine-associated chest pain. O'Conor K; Chang AM; Wu AH; Hollander JE Am J Emerg Med; 2013 Apr; 31(4):664-9. PubMed ID: 23380098 [TBL] [Abstract][Full Text] [Related]
32. Effect of atorvastatin on risk of recurrent cardiovascular events after an acute coronary syndrome associated with high soluble CD40 ligand in the Myocardial Ischemia Reduction with Aggressive Cholesterol Lowering (MIRACL) Study. Kinlay S; Schwartz GG; Olsson AG; Rifai N; Sasiela WJ; Szarek M; Ganz P; Libby P; Circulation; 2004 Jul; 110(4):386-91. PubMed ID: 15262833 [TBL] [Abstract][Full Text] [Related]
33. Efficacy and tolerability of combination therapy with valsartan plus hydrochlorothiazide compared with amlodipine monotherapy in hypertensive patients with other cardiovascular risk factors: the VAST study. Ruilope LM; Malacco E; Khder Y; Kandra A; Bönner G; Heintz D Clin Ther; 2005 May; 27(5):578-87. PubMed ID: 15978306 [TBL] [Abstract][Full Text] [Related]
34. [Serum sCD40L detection for risk evaluation of acute coronary syndromes]. Xu BL; Bei CH; Wang R; Lei XX Nan Fang Yi Ke Da Xue Xue Bao; 2006 Nov; 26(11):1656-7. PubMed ID: 17121725 [TBL] [Abstract][Full Text] [Related]
35. Homocysteine-lowering therapy does not affect inflammatory markers of atherosclerosis in patients with stable coronary artery disease. Bleie Ø; Semb AG; Grundt H; Nordrehaug JE; Vollset SE; Ueland PM; Nilsen DW; Bakken AM; Refsum H; Nygård OK J Intern Med; 2007 Aug; 262(2):244-53. PubMed ID: 17645592 [TBL] [Abstract][Full Text] [Related]
36. Berberine ameliorates inflammation in patients with acute coronary syndrome following percutaneous coronary intervention. Meng S; Wang LS; Huang ZQ; Zhou Q; Sun YG; Cao JT; Li YG; Wang CQ Clin Exp Pharmacol Physiol; 2012 May; 39(5):406-11. PubMed ID: 22220931 [TBL] [Abstract][Full Text] [Related]
37. Beta-blockers and cocaine: still a bad idea. Gupta AK; Greller HA; Hoffman RS Arch Intern Med; 2010 Nov; 170(20):1859-60; author reply 1860. PubMed ID: 21059982 [No Abstract] [Full Text] [Related]
38. [Oxidative stress and inflammatory markers in cocaine users with acute coronary syndrome]. Domínguez-Rodríguez A; Abreu-González P; Enjuanes-Grau C; Blanco-Palacios G; Angeles Pérez-Carrillo Mde L; Burillo-Putze G Med Clin (Barc); 2010 Feb; 134(4):152-5. PubMed ID: 19819485 [TBL] [Abstract][Full Text] [Related]
39. Intravenous Cocaine Results in an Acute Decrease in Levels of Biomarkers of Vascular Inflammation in Humans. Gupta K; Sharma R; Singh V; Masoomi R; Dileepan KN; He J; Smith DD; Dawn B; Grasing K Cardiovasc Toxicol; 2018 Aug; 18(4):295-303. PubMed ID: 29372505 [TBL] [Abstract][Full Text] [Related]